Page 13 - Read Online
P. 13

Santoni et al. J Cancer Metastasis Treat 2020;6:22  I  http://dx.doi.org/10.20517/2394-4722.2020.49                      Page 9 of 14

               accelerated cell cycle progression and repressed apoptosis. SNHG3 facilitated the malignant progression
                                                                   Cip1
               of glioma through epigenetically repressing KLF2 and p21  via recruitment of the enhancer of zeste
               homolog 2 to the promoter of KLF2 and p21 Cip1[60] . Similarly, overexpression of SNHG6 promotes the
               malignant phenotype, while loss-of-function revealed that the silencing of SNHG6 inhibits glioma cell
                                                [61]
                            Cip1
               growth in a p21 -dependent manner .
               The LncRNA PTEN pseudogene-1 (PTENP1) has been described to be involved in the development and
               progression of several cancers. However, little is known about the molecular mechanism by which lncRNA
               PTENP1 affects the development and progression of gliomas. Overexpression of PTENP1 suppressed
               SHG44 expression as well as U251 cell proliferation, invasion and migration by inducing p21  expression
                                                                                              Cip1
                                        [62]
               while inhibiting p38 signaling .
                                               Cip1
               Among LincRNA, the LincRNA-p21  is an intergenic LncRNA which resides on the chromosome 17,
                                 Cip1
               upstream of the p21 gene. It was identified ten years ago as being one of the eleven LincRNAs that are
                                                                       [63]
               increased in expression in response to p-53 induced DNA damage .
                           Cip1
               LincRNA-p21  is the downstream target of p53 and controls the cell cycle, damage of DNA and its repair
               process . The LincRNA-p21  suppresses the p53-dependent transcription activity and affects p53-repressed
                                       Cip1
                     [63]
               genes. It is required to trigger p53-dependent apoptosis of DNA damaged cells through physical association
               with the ribonucleoprotein K (hnRNP-K) .
                                                  [64]
               LincRNA-p21  also regulates the G1/S checkpoint of the cell cycle by modulating the expression of
                           Cip1
               its neighboring gene p21 Cip1[65]  and mediating radiation-induced apoptosis [66,67] . LincRNA-p21 Cip1  is a
                                                                                                       [68]
               potent suppressor of GSC and works by triggering apoptosis through the NOXA pro-apoptotic gene .
               It negatively regulates β-catenin activity in GSCs. Downregulation of LincRNA-p21 Cip1  in GSCs results
               in upregulation of Hu antigen R (HuR), and this is caused by miR-146b-5p down-regulation. Moreover,
                                      Cip1
               knockout of LincRNA-p21  or HuR was shown to increase GSC β-catenin expression, stemness and GSCs
               radioresistance . Previous findings also showed that LincRNA-p21  is a hypoxia-responsive lncRNA
                                                                           Cip1
                            [51]
               able to regulate the cell cycle and apoptosis. It has also been shown to be responsible for the Warburg effect
                                                                             Cip1
               in cervical cancer. Although hypoxia was found to increase LincRNA-p21  expression in U251MG glioma
               cell line, its functions in hypoxic glioma remain unknown. Knockdown of LincRNA-p21 induced G2/M
               phase arrest, promoted apoptosis, decreased cell proliferation and motility, and also reduced autophagy
                                                        [69]
               through the HIF-1/Akt/mTOR/P70S6K pathway . These findings are suggestive of a mechanism by which
               LincRNA-p21  enhances the radiosensitivity of hypoxic tumor cells.
                           Cip1

               The antisense FAM83H RNA1 (FAM83H-AS1) is known to be upregulated in glioma. Silencing of
               FAM83H-AS1 suppressed glioma proliferation and apoptosis. FAM83H-AS1 inhibits CDKN1A expression
                                                                                                 [70]
               by recruiting EZH2 to the promoter of CDKN1A, thereby influencing cell cycle and proliferation .
               LincRNAs also regulates cellular senescence. Thus, LincRNA-ASEN, which is expressed in prematurely
                                                                                   Cip1
               senescent cells, has been shown to repress cellular senescence by reducing p21  expression, both during
               and post-transcription. The complex formed by the interaction between Linc-ASEN and UPF1 can
                          Cip1
               suppress p21  transcription through the recruitment of Polycomb Repressive Complex 1 and 2 (PRC1
               and PRC2) to the p21 locus. This prevents binding of the transcriptional activator p53 to the p21 promoter
                                        [64]
               through histone modification .
                                                          CIP1
                                                                              CIP1
               CLINICAL ROLE OF MIRNA TARGETING P21  AND LNCRNA-P21  IN GLIOMAS
               The identification of glioma-related biomarkers is an urgent necessity as it would enable the development
               of new therapeutic approaches, while improving the ability to predict responsiveness to chemo- and
   8   9   10   11   12   13   14   15   16   17   18